Ascendis Pharma A/S Ordinary Share
Market Cap
17B
Short interest (Jul 15)
4.7%
Net Short (Jul 27 ): -0.1%
Borrow Fee
0.37%
↑ 38.5%
Available Shares
700K
↑ 22.4%
Price Chart
Company Overview
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.